AspirinCyclooxygenase 2Cyclooxygenase InhibitorsCyclooxygenase 1Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesPlatelet Aggregation InhibitorsIbuprofenDinoprostoneThromboxane B2IndomethacinProstaglandinsNaproxenDiclofenacIsoenzymesArachidonic AcidSalicylatesPlatelet AggregationPyrazolesSulfonamidesFlurbiprofenTiclopidinePiroxicamNitrobenzenesStomach UlcerPlatelet Function TestsGastrointestinal DiseasesThromboxane A2Drug Therapy, CombinationBlood PlateletsThromboxanesLipoxygenase InhibitorsDose-Response Relationship, DrugAcetaminophenThiazines6-Ketoprostaglandin F1 alphaGastrointestinal HemorrhageEpoprostenolSodium SalicylateArachidonic AcidsSulfonesMembrane ProteinsLipoxygenaseGastric MucosaLactonesPeptic UlcerKetoprofenAsthma, Aspirin-InducedPeptic Ulcer HemorrhageFibrinolytic AgentsEicosanoidsThromboxane-A SynthaseRisk FactorsDouble-Blind MethodMasoprocolKetorolacHemorrhagePlatelet ActivationBleeding TimeLipoxinsAnticoagulantsTime FactorsWarfarinDrug InteractionsTablets, Enteric-CoatedProstaglandins EHydroxyeicosatetraenoic AcidsProspective StudiesNitric OxideEtodolacArachidonate 5-LipoxygenaseTolmetinThrombosisTreatment OutcomeAnalgesics, Non-NarcoticAnti-Ulcer AgentsProton Pump InhibitorsIntramolecular OxidoreductasesDrug HypersensitivityStomach DiseasesDinoprostProstaglandins GAnti-Inflammatory AgentsMeclofenamic AcidSeminal VesiclesSulfinpyrazoneDipyridamoleMyocardial InfarctionReceptors, Prostaglandin EMisoprostolDrug Resistance4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineAnticarcinogenic Agents5,8,11,14-Eicosatetraynoic AcidArthritisChemopreventionCells, CulturedColorectal NeoplasmsVasodilation